Financial Performance - Revenue for Q1 2024 reached ¥205,546,468.23, an increase of 31.84% compared to ¥155,900,697.93 in the same period last year[5] - Net profit attributable to shareholders was ¥9,691,410.80, up 27.89% from ¥7,578,036.60 year-on-year[5] - The company recorded a profit before tax of ¥11,370,117.72, a 41.63% increase from ¥8,027,814.36 in the previous year[13] - The comprehensive income for Q1 2024 was CNY 8,603,015.69, compared to CNY 6,476,518.05 in Q1 2023, showing an increase of 32.8%[28] - The net profit for Q1 2024 reached CNY 9,691,410.80, a 28.0% increase from CNY 7,578,036.60 in Q1 2023[27] Cash Flow - Operating cash flow improved significantly, with a net cash flow of ¥8,991,459.32, a 187.83% increase from a negative cash flow of ¥10,237,514.32 in the previous year[5] - The net cash flow from operating activities increased to ¥8,991,459.32, a significant improvement of 187.83% compared to the previous period, primarily due to increased cash inflows from sales growth[14] - The net cash flow from investing activities reached ¥11,591,784.48, reflecting a 294.53% increase, mainly attributed to the maturity of time deposits[14] - The net cash flow from financing activities decreased to ¥3,291,989.85, a decline of 87.96%, primarily due to a reduction in bank loans compared to the previous year[14] - Total cash inflow from operating activities was ¥226,405,197.33, compared to ¥163,848,100.33 in the prior year, reflecting a year-over-year increase of approximately 38%[31] Assets and Liabilities - Total assets at the end of the quarter were ¥1,534,805,622.22, a 2.61% increase from ¥1,495,774,118.02 at the end of the previous year[5] - The total liabilities increased significantly, with accounts payable rising by 196.38% to ¥52,527,382.43, primarily due to increased procurement costs[10] - The total liabilities increased to CNY 341,831,358.71 in Q1 2024, up from CNY 311,402,870.20 in Q1 2023, marking a rise of 9.8%[24] - The company's total equity as of Q1 2024 was CNY 1,192,974,263.51, an increase from CNY 1,184,371,247.82 in Q1 2023, indicating a growth of 0.7%[24] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 19,039, with no preferred shareholders having restored voting rights[17] - The largest shareholder, Gao Liqing, holds 35.56% of the shares, amounting to 48,510,000 shares[17] - The second-largest shareholder, Ningbo Lingying Trading Co., Ltd., owns 18.55% of the shares, totaling 25,300,000 shares[17] Research and Development - Research and development expenses increased by 61.28% to ¥9,720,016.72, reflecting greater investment in product development[13] - Research and development expenses for Q1 2024 amounted to CNY 9,720,016.72, which is a 61.5% increase compared to CNY 6,026,882.75 in Q1 2023[27] Inventory and Costs - The company reported a significant increase in inventory, which rose by 24.39% to ¥192,898,972.33, attributed to increased sales volume[10] - The gross profit margin decreased slightly, with operating costs rising by 36.00% to ¥166,366,301.07 due to increased sales[13] - The total operating costs for Q1 2024 were CNY 195,512,328.47, up 32.8% from CNY 147,116,804.62 in the same period last year[26] Other Financial Metrics - The weighted average return on equity decreased to 0.82%, down 0.92% from the previous year[5] - The basic and diluted earnings per share for Q1 2024 remained at CNY 0.07, consistent with Q1 2023[28] - The company reported a financial asset impairment loss of CNY 1,462,298.74 in Q1 2024, compared to a loss of CNY 891,654.28 in Q1 2023[27]
朗威股份(301202) - 2024 Q1 - 季度财报